about
Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice.Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study.Recovery from herpes simplex encephalitis: selective impairment of specific semantic categories with neuroradiological correlation.Pesticide exposure assessed through agricultural crop proximity and risk of amyotrophic lateral sclerosis.1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity.Magnetic fields exposure from high-voltage power lines and risk of amyotrophic lateral sclerosis in two Italian populations.Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy.Anderson-Fabry's disease: neuropathological and neurochemical investigation.Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial.Central pontine and extrapontine myelinolysis despite careful correction of hyponatremia: clinical and neuropathological findings of a case.Nerve ablation after bronchial thermoplasty and sustained improvement in severe asthma.Epidemiology of amyotrophic lateral sclerosis in Emilia Romagna Region (Italy): A population based studyCreutzfeld-Jakob disease: clinical, EEG and neuropathological findings in a cluster of eleven patientsTangier neuropathy in ItalyRisk of sporadic amyotrophic lateral sclerosis associated with seropositivity for herpesviruses and echovirus-7Environmental exposure to trace elements and risk of amyotrophic lateral sclerosis: a population-based case-control studyClinical and molecular studies of 73 Italian families with autosomal dominant cerebellar ataxia type I: SCA1 and SCA2 are the most common genotypesMiller Fisher syndrome with positivity of anti-GAD antibodies
P50
Q34656871-BC57DBCA-9980-4D71-80EF-5D924D0FAB67Q35891811-74A2CA04-C893-483B-9EF4-3140FF5F9D57Q38485283-FCFD1AA1-7196-4AAF-8277-E5ADA41CA39CQ40066291-E99C240E-C868-4B9F-81F6-E742ED8B562BQ40076266-9947BF8A-7788-4F5C-ACAE-4D27FCCFE751Q40177968-EA560D5F-6150-4DE0-821D-C740E052736CQ41553914-EF5DE3BC-7D9E-4127-9396-D0B3185AACCFQ42451968-C320298B-C2C1-45B0-BE92-C2200B56A3FFQ43497178-EE3C2E13-7BAB-4C4C-B8C3-F0EF20C1FB93Q48420980-BC01ADE6-A5A8-43C6-A981-3056183A66E1Q50052790-87C1FE62-38B7-4166-A041-B3C5C2F57D28Q61965736-845D1860-0772-4C32-8E94-8A78CE6653D2Q70263499-3E30E0F9-B02A-45C1-9496-A35C8035D62EQ72489326-CFCC1E3B-0DE7-4B36-B5D4-A747D1707049Q73359476-8A168AE5-73C4-4941-A714-13BFD15D097BQ74477216-CA3CCA8A-7C0B-46DD-B07C-400DE52BD8D2Q77983035-D78E68F6-2BB5-46C0-9D29-52DC766C5C37Q86454537-76175BB0-03D2-4456-9E23-714FEECE2A7A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Vladimiro Pietrini
@ast
Vladimiro Pietrini
@en
Vladimiro Pietrini
@es
Vladimiro Pietrini
@nl
type
label
Vladimiro Pietrini
@ast
Vladimiro Pietrini
@en
Vladimiro Pietrini
@es
Vladimiro Pietrini
@nl
prefLabel
Vladimiro Pietrini
@ast
Vladimiro Pietrini
@en
Vladimiro Pietrini
@es
Vladimiro Pietrini
@nl
P106
P1153
57193934811
7004145998
P21
P31
P496
0000-0002-7521-8093